Wieslawa H. Dragowska

Vancouver, BC V5Z1L3, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In Vivo.

Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In Vivo.

Journal: Pharmaceutics

Published: September 18, 2024

Copper-CX-5461: A novel liposomal formulation for a small molecule rRNA synthesis inhibitor.

Copper-CX-5461: A novel liposomal formulation for a small molecule rRNA synthesis inhibitor.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: March 01, 2018

Development of a copper-clioquinol formulation suitable for intravenous use.

Development of a copper-clioquinol formulation suitable for intravenous use.

Journal: Drug delivery and translational research

Published: December 17, 2017

A new quinoline-based chemical probe inhibits the autophagy-related cysteine protease ATG4B.

A new quinoline-based chemical probe inhibits the autophagy-related cysteine protease ATG4B.

Journal: Scientific reports

Published: October 04, 2017

Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.

Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.

Journal: International journal of nanomedicine

Published: June 16, 2017

Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity status.

Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity status.

Journal: Investigational new drugs

Published: May 19, 2017

In vitro assay for measuring real time topotecan release from liposomes: release kinetics and cellular internalization.

In vitro assay for measuring real time topotecan release from liposomes: release kinetics and cellular internalization.

Journal: Drug delivery and translational research

Published: April 23, 2017

Identification of breast cancer cell subtypes sensitive to ATG4B inhibition.

Identification of breast cancer cell subtypes sensitive to ATG4B inhibition.

Journal: Oncotarget

Published: March 20, 2016

Overexpression of HER-2 in MDA-MB-435/LCC6 Tumours is Associated with Higher Metabolic Activity and Lower Energy Stress.

Overexpression of HER-2 in MDA-MB-435/LCC6 Tumours is Associated with Higher Metabolic Activity and Lower Energy Stress.

Journal: Scientific reports

Published: September 02, 2015

3'-Phosphoadenosine 5'-phosphosulfate synthase 1 (PAPSS1) knockdown sensitizes non-small cell lung cancer cells to DNA damaging agents.

3'-Phosphoadenosine 5'-phosphosulfate synthase 1 (PAPSS1) knockdown sensitizes non-small cell lung cancer cells to DNA damaging agents.

Journal: Oncotarget

Published: November 19, 2014

Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancer.

Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 12, 2014

Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer.

Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer.

Journal: PloS one

Published: March 15, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026